Ziv-Aflibercept for Advanced Progressive Carcinoid Tumors

Clinical trial NCT01782443 · COMPLETED

Trial details

NCT number: NCT01782443
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoid Tumor

Start date: 2013-02-13
Primary completion: 2021-03-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.